On Tuesday, Atossa Therapeutics Inc (NASDAQ: ATOS) opened lower -4.62% from the last session, before settling in for the closing price of $0.72. Price fluctuations for ATOS have ranged from $0.55 to $1.29 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 36.92%. Company’s average yearly earnings per share was noted -25.00% at the time writing. With a float of $129.12 million, this company’s outstanding shares have now reached $129.17 million.
The extent of productivity of a business whose workforce counts for 15 workers is very important to gauge.
Atossa Therapeutics Inc (ATOS) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Atossa Therapeutics Inc is 0.04%, while institutional ownership is 19.43%. The most recent insider transaction that took place on May 21 ’25, was worth 9,887. In this transaction President & CEO of this company bought 11,239 shares at a rate of $0.88, taking the stock ownership to the 13,898 shares. Before that another transaction happened on Mar 26 ’25, when Company’s Director bought 10,000 for $0.70, making the entire transaction worth $7,000. This insider now owns 10,257 shares in total.
Atossa Therapeutics Inc (ATOS) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.05 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.06) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -25.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -17.57% during the next five years compared to 36.92% growth over the previous five years of trading.
Atossa Therapeutics Inc (NASDAQ: ATOS) Trading Performance Indicators
Check out the current performance indicators for Atossa Therapeutics Inc (ATOS). In the past quarter, the stock posted a quick ratio of 6.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.23, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.29 in one year’s time.
Technical Analysis of Atossa Therapeutics Inc (ATOS)
The latest stats from [Atossa Therapeutics Inc, ATOS] show that its last 5-days average volume of 1.0 million was superior to 0.88 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 7.40%.
During the past 100 days, Atossa Therapeutics Inc’s (ATOS) raw stochastic average was set at 2.89%, which indicates a significant decrease from 5.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0524 in the past 14 days, which was higher than the 0.0472 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8292, while its 200-day Moving Average is $0.8180. Now, the first resistance to watch is $0.7090. This is followed by the second major resistance level at $0.7340. The third major resistance level sits at $0.7554. If the price goes on to break the first support level at $0.6626, it is likely to go to the next support level at $0.6412. Assuming the price breaks the second support level, the third support level stands at $0.6162.
Atossa Therapeutics Inc (NASDAQ: ATOS) Key Stats
There are currently 129,171K shares outstanding in the company with a market cap of 88.36 million. Presently, the company’s annual sales total 0 K according to its annual income of -25,500 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -8,690 K.
